Đang chuẩn bị liên kết để tải về tài liệu:
báo cáo hóa học:" Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases"

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí hóa học đề tài : Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases | Garin et al. Health and Quality of Life Outcomes 2010 8 51 http www.hqlo.eom content 8 1 51 I HEALTH AND QUALITY OF LIFE OUTCOMES RESEARCH Open Access Validation of the World Health Organization Disability Assessment Schedule WHODAS-2 in patients with chronic diseases Olatz Garin 1 2 Jose Luis Ayuso-Mateos3 Josué Almansa1 Marta Nieto3 Somnath Chatterji4 Gemma Vilagut1 2 Jordi Alonso1 2 Alarcos Cieza5 Olga Svetskova6 Helena Burger7 Vittorio Racca8 Carlo Francescutti9 Eduard Vieta10 Nenad Kostanjsek4 Alberto Raggi11 Matilde Leonardi11 Montse Ferrer 1 2 12 for the MHADIE consortium Abstract Background The WHODAS-2 is a disability assessment instrument based on the conceptual framework of the International Classification of Functioning Disability and Health ICF . It provides a global measure of disability and 7 domain-specific scores. The aim of this study was to assess WHODAS-2 conceptual model and metric properties in a set of chronic and prevalent clinical conditions accounting for a wide scope of disability in Europe. Methods 1 119 patients with one of 13 chronic conditions were recruited in 7 European centres. Participants were clinically evaluated and administered the WHODAS-2 and the SF-36 at baseline 6 weeks and 3 months of follow-up. The latent structure was explored and confirmed by factor analysis FA . Reliability was assessed in terms of internal consistency Cronbach s alpha and reproducibility intra-class correlation coefficients ICC . Construct validity was evaluated by correlating the WHODAS-2 and SF-36 domains and comparing known groups based on the clinical-severity and work status. Effect size ES coefficient was used to assess responsiveness. To assess reproducibility and responsiveness subsamples of stable at 6 weeks and improved after 3 moths patients were defined respectively according to changes in their clinical-severity. Results The satisfactory FA goodness of fit indexes confirmed a second order factor structure with 7 dimensions and a global .